ForAir 250 CFC Free Inhaler

ForAir 250 CFC Free Inhaler is pharmaceutical drug formulated with the combination of Salmeterol and fluticasone propionate is used in treating the symptoms of Asthma and Chronic Obstructive Pulmonary Disease (COPD) that may work by relaxing airway muscles and also by reducing airway inflammation. The CFC-free formulation uses an environmentally friendly propellant system.

Key Features

How does ForAir 250 CFC Free Inhaler work?

• Relaxing and widening the airways

  Salmeterol xinafoate may stimulates beta2-adrenergic receptors in the respiratory tract, followed by activating adenylyl cyclase, this may cause relaxation of bronchial smooth muscle, resulting in bronchodilation lasting up to 12 hours.

• Reducing airway inflammation

  Fluticasone propionate is a potent corticosteroid that inhibits the production of inflammatory mediators such as prostaglandins, leukotrienes, and cytokines. This may reduce swelling, mucus production, and irritation in the airways.

• Comprehensive symptom control

  The combined effects improve lung function, reduce exacerbations, decrease the need for rescue medications, and enhance quality of life for patients with asthma and COPD.

Dosage

2 inhalations twice daily (morning and evening), approximately 12 hours apart, or as directed by your doctor.

How to use ForAir 250 CFC Free Inhaler?

• Shake the inhaler well for 5 seconds before each use.
• Prime before first use or if not used for more than 7 days by releasing 4 test sprays into the air.
• Rinse your mouth thoroughly with water after each use and spit it out to prevent oral thrush.
• Use regularly as prescribed, even when you feel well, to maintain effective disease control.
• It is recommended to consult a doctor or Pulmonologists prior to using this inhaler.

Uses

• It can be used in treating the symptoms of Asthma.
• Chronic Obstructive Pulmonary Disease (COPD) can be treated by ForAir 250 CFC Free Inhaler.
• It can be also used in preventing Bronchospasm.

Side Effects

• Headache
• Nausea
• Cough
• Tremors
• Dizziness
• Nasopharyngitis
• Hoarseness of voice
• Palpitations
• Musculoskeletal Pain
• Oropharyngeal candidiasis
• Throat irritation and sore throat
• Upper respiratory tract infection

Interactions

• ForAir 250 may interact with Beta-blockers (e.g., propranolol, metoprolol), which can decrease Salmeterol effectiveness and cause paradoxical bronchospasm.
• Inhaler may interact with CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole), significantly increasing Fluticasone propionate exposure and systemic corticosteroid side effects.
• Inhaler may interact with MAOIs and Tricyclic antidepressants, potentiating cardiovascular effects of Salmeterol.
• Inhaler may interact with Diuretics and Xanthine derivatives (e.g., theophylline), increasing the risk of hypokalaemia and cardiovascular side effects.
• Inhaler may interact with other sympathomimetic agents, which can potentiate cardiovascular effects.

Pharmacokinetics

• Pharmacokinetics of ForAir 250 involves absorption of both components through lung tissue.
• Salmeterol acts locally with peak plasma concentrations within 5-10 minutes and bronchodilatory effects of inhaler may last up to 12 hours.
• It is metabolized in the liver. Fluticasone propionate has low oral bioavailability but higher pulmonary bioavailability when inhaled. It is highly lipophilic, allowing prolonged airway retention, and is metabolized by CYP3A4 to inactive metabolites.

Precautions

• Do not use if allergic to Salmeterol, Fluticasone propionate, or any ingredients in the formulation.
• Use with caution in patients with heart disease, irregular heartbeat, or
• Monitor blood sugar levels closely as corticosteroids and beta-agonists may increase blood glucose.
• Use with caution in patients with glaucoma. Regular eye examinations advisable during prolonged therapy.
• Use only if benefits outweigh risks. Consult your doctor before using if pregnant or breastfeeding
• Not recommended for children below 4 years. For children 4-11 years, use only under medical supervision.
• Correct inhaler technique is essential. Poor coordination may be overcome by using a spacer device.

Conclusion

ForAir 250 CFC Free Inhaler is an effective combination medication for treating asthma and COPD, just by combining a long-acting bronchodilator with a potent corticosteroid, this medication addresses both bronchospastic and inflammatory components, improving lung function, reducing exacerbations, and enhancing quality of life. ForAir  medication can be used regularly as prescribed, and also be maintain proper inhaler techniques, and always carry a rescue inhaler for sudden breathing difficulties. It is advised to consult a medical professional prior using any such medications to avoid any unwanted interactions.

References

https://doi.org/10.1089/jam.1995.8.suppl_1.s-41 

https://www.ncbi.nlm.nih.gov/books/NBK557453/ 

https://doi.org/10.1016/j.rmed.2012.10.025 

FAQ’s